Drug Shortage Report for SULCRATE

Last updated on 2020-01-15 History
Report ID 100515
Drug Identification Number 02100622
Brand name SULCRATE
Common or Proper name sucralfate
Company Name APTALIS PHARMA CANADA ULC
Market Status MARKETED
Active Ingredient(s) SUCRALFATE
Strength(s) 1G
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code A02BX
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-12-06
Estimated end date
Actual end date 2020-01-14
Shortage status Resolved
Updated date 2020-01-15
Company comments
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-01-15 English Compare
v6 2020-01-14 French Compare
v5 2020-01-14 English Compare
v4 2020-01-14 French Compare
v3 2020-01-14 English Compare
v2 2019-12-07 French Compare
v1 2019-12-07 English Compare